These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 351632)

  • 21. [Infusion treatment in shock].
    Esser H
    Infusionsther Klin Ernahr; 1975 Dec; 2(6):424-8. PubMed ID: 1344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood volume and plasma protein. 3. Changes in blood volume and plasma proteins after bleeding and immediate substitution with Macrodex, Rheomacrodex and Physiogel in the splenecromized dog.
    Rieger A
    Acta Chir Scand Suppl; 1967; 379():22-38. PubMed ID: 5243638
    [No Abstract]   [Full Text] [Related]  

  • 23. [CLINICAL USE OF A LOW MOLECULAR WEIGHT DEXTRAN].
    CORMIER JM; SULZER J
    Presse Med (1893); 1964 Dec; 72():3429-32. PubMed ID: 14231417
    [No Abstract]   [Full Text] [Related]  

  • 24. [Routine measures in the prevention of postoperative thrombosis and embolism. Based on a multicentre trial of about 4000 patients with dextran or low-dose heparin prevention].
    Lund T
    Tidsskr Nor Laegeforen; 1980 Aug; 100(22):1267-9. PubMed ID: 6160644
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood substitutes as a component of transfusion-infusion therapy of hemorrhages in obstetrical practice (literature survey)].
    Slepykh AS; Repina MA
    Vopr Okhr Materin Det; 1974 Nov; 19(11):74-7. PubMed ID: 4612966
    [No Abstract]   [Full Text] [Related]  

  • 26. Hydroxyethyl starch as a plasma expander in hemorrhagic shock.
    Murray GF; Solanke T; Thompson WL; Ballinger WF
    Surg Forum; 1965; 16():34-5. PubMed ID: 5835186
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood volume and plasma protein. IV. Importance of thoracic-duct lymph in restitution of plasma volume and plasma proteins after bleeding and immediate substitution in the splenectomized dog.
    Liljedahl SO; Rieger A
    Acta Chir Scand Suppl; 1967; 379():39-5. PubMed ID: 5243639
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of reduced glutathione for the improvement of the therapeutic effectiveness of blood and plasma substitutes in the treatment of haemorrhagic shock (experimental study).
    Horejsí J; Stĕrba O
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(2):220-5. PubMed ID: 4167557
    [No Abstract]   [Full Text] [Related]  

  • 29. Review of present status of prophylaxis of venous thromboembolism.
    Kakkar VV
    Proc R Soc Med; 1974 Aug; 67(8):706-8. PubMed ID: 4608128
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of fluosol-DA on blood coagulation-fibrinolysis system in canine hemorrhagic shock (author's transl)].
    Tsukada S
    Masui; 1979 Sep; 28(9):929-37. PubMed ID: 501912
    [No Abstract]   [Full Text] [Related]  

  • 31. Dextran 75 in the prophylaxis of deep venous thrombosis and pulmonary embolism.
    Wedge JH; Kirkaldy-Willis WH; Hayton RC
    Can J Surg; 1974 Jan; 17(1):45-8. PubMed ID: 4590794
    [No Abstract]   [Full Text] [Related]  

  • 32. [The influencing of posthemorrhagic hypotension and hemorrhagic shock using hyperbaric oxygenation and plasma substitute solutions (experiments on dogs)].
    Mrázek R; Holek J; Szeligová L; Sevcík V; Buriánová L; Chaloupka V
    Bratisl Lek Listy; 1970; 53(1):48-60. PubMed ID: 5436360
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of dextran, gelatine and homologous plasma on circulation in shock caused by severe anemia in the dog].
    Dietze W; Rentrop P; Schmidt HD; Schmier J
    Prakt Anaesth; 1976 Apr; 11(2):59-68. PubMed ID: 959132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Incidence of Sludge in postoperative complications. Value of low molecular weight (40,000) dextran].
    Estour E; Gaillard P
    Lyon Med; 1967 Jul; 218(28):81-8. PubMed ID: 5622001
    [No Abstract]   [Full Text] [Related]  

  • 35. [Shock and infusion treatment].
    Ikeda K
    Masui; 1973 Feb; 22(2):133-7. PubMed ID: 4736111
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of thrombo-embolism with dextran 70 and heparin in patients with femoral neck fractures.
    Myrvold HE; Persson JE; Svensson B; Wallensten S; Vikterlöf KJ
    Acta Chir Scand; 1973; 139(7):609-16. PubMed ID: 4768533
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma substitutes past and present.
    Hässig A; Stampfli K
    Bibl Haematol; 1969; 33():1-8. PubMed ID: 4911197
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of postoperative thromboembolic complications. A prospective comparison between dextran 70, dihydroergotamine heparin and a sulphated polysaccharide.
    Bergqvist D; Efsing HO; Hallböök T; Lindblad B
    Acta Chir Scand; 1980; 146(8):559-68. PubMed ID: 6164204
    [No Abstract]   [Full Text] [Related]  

  • 39. An assessment of the potential use of anionic dextrans as a plasma substitute.
    Chang RL; Crawford MP; West MD
    J Biomed Eng; 1980 Jan; 2(1):41-4. PubMed ID: 7359897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of the plasma substitutes hydroxyethyl starch and dextrane-60 on the kidney function of dogs in acute haemorrhagic shock (author's transl)].
    Heidenreich O; aus der Mühlen K; Heintze K
    Anaesthesist; 1975 May; 24(5):239-43. PubMed ID: 56906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.